ProfileGDS4718 / 201699_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 95% 95% 95% 95% 95% 95% 96% 95% 93% 96% 97% 94% 96% 96% 96% 95% 95% 97% 94% 94% 96% 95% 95% 96% 96% 96% 92% 95% 94% 95% 95% 95% 93% 96% 96% 96% 96% 94% 94% 96% 95% 96% 96% 97% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.449595
GSM549102patient 115, normal, homogenized [OPG study]10.33795
GSM549104patient 119, normal, homogenized [OPG study]10.373695
GSM549108patient 138, normal, homogenized [OPG study]10.261695
GSM549119patient 077, normal, homogenized [OPG study]10.424395
GSM549133patient 032, cancer, homogenized [OPG study]10.336295
GSM549139patient 042, cancer, homogenized [OPG study]10.520196
GSM549099patient 107, normal, homogenized [OPG study]10.287695
GSM549109patient 139, normal, homogenized [OPG study]9.8866493
GSM549110patient 046, normal, homogenized [OPG study]10.687296
GSM549114patient 063, normal, homogenized [OPG study]10.974897
GSM549122patient 082, normal, homogenized [OPG study]9.9315494
GSM549134patient 033, cancer, homogenized [OPG study]10.469696
GSM549136patient 036, cancer, homogenized [OPG study]10.433396
GSM549140patient 044, cancer, homogenized [OPG study]10.444996
GSM549111patient 047, normal, homogenized [OPG study]10.496595
GSM549113patient 057, normal, homogenized [OPG study]10.401395
GSM549132patient 031, cancer, homogenized [OPG study]10.89997
GSM549137patient 038, cancer, homogenized [OPG study]9.9572194
GSM549142patient 047, cancer, homogenized [OPG study]9.3760694
GSM549100patient 110, normal, homogenized [OPG study]10.567896
GSM549107patient 135, normal, homogenized [OPG study]10.465795
GSM549115patient 068, normal, homogenized [OPG study]10.619395
GSM549116patient 072, normal, homogenized [OPG study]10.587596
GSM549120patient 078, normal, homogenized [OPG study]10.730896
GSM549131patient 030, cancer, homogenized [OPG study]10.632796
GSM549118patient 074, normal, homogenized [OPG study]9.7155992
GSM549129patient 027, cancer, homogenized [OPG study]10.086295
GSM549123patient 088, normal, homogenized [OPG study]9.9557694
GSM549124patient 006, cancer, homogenized [OPG study]9.9248295
GSM549126patient 015, cancer, homogenized [OPG study]10.087995
GSM549128patient 025, cancer, homogenized [OPG study]10.197295
GSM549103patient 117, normal, homogenized [OPG study]9.6520893
GSM549117patient 073, normal, homogenized [OPG study]10.710196
GSM549138patient 041, cancer, homogenized [OPG study]10.626596
GSM549141patient 045, cancer, homogenized [OPG study]10.645896
GSM549130patient 028, cancer, homogenized [OPG study]10.22896
GSM549101patient 111, normal, homogenized [OPG study]10.024594
GSM549105patient 128, normal, homogenized [OPG study]9.9737794
GSM549106patient 134, normal, homogenized [OPG study]10.669596
GSM549112patient 048, normal, homogenized [OPG study]10.281195
GSM549125patient 011, cancer, homogenized [OPG study]10.331396
GSM549127patient 024, cancer, homogenized [OPG study]10.469496
GSM549135patient 035, cancer, homogenized [OPG study]10.807997